MoonLake Immunotherapeutics Increase (Decrease) in Accounts Payable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$6.34M, a 224.99% decline year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$6.17M, a 304.88% decline year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $4.27M.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $8.20M, a 47.32% increase year-over-year.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for fiscal 2025 was $20.56M, a 187.35% increase from fiscal 2024.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for fiscal 2024 was $7.16M, a 351.99% increase from fiscal 2023.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for fiscal 2023 was $1.58M.
- MoonLake Immunotherapeutics increase (decrease) in accounts payable for fiscal 2022 was -$1.31M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 10 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$12.52M 10-Q · filed 2026-08-10 | -$8.24M derived: sum of 3 quarters · filed 2026-08-10 | -$42.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | -$6.17M 10-Q · filed 2026-05-11 | -$1.90M derived: sum of 2 quarters · filed 2026-05-11 | $6.30M derived: sum of 3 quarters · filed 2026-05-11 | $11.37M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.47M derived: sum of 2 quarters · filed 2026-02-25 | $17.55M derived: sum of 3 quarters · filed 2026-08-10 | $20.56M 10-K · filed 2026-02-25 | |||||
| 2025-09-30 | $8.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.28M derived: sum of 2 quarters · filed 2026-08-10 | $16.29M 10-Q · filed 2025-11-05 | $14.57M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $8.09M 10-Q · filed 2026-08-10 | $6.37M derived: sum of 3 quarters · filed 2026-08-10 | $11.94M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | $3.01M 10-Q · filed 2026-05-11 | $1.29M derived: sum of 2 quarters · filed 2026-05-11 | $6.86M derived: sum of 3 quarters · filed 2026-05-11 | $8.52M derived: sum of 4 quarters · filed 2026-05-11 | |||||
| 2024-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.85M derived: sum of 2 quarters · filed 2026-02-25 | $5.51M derived: sum of 3 quarters · filed 2026-02-25 | $7.16M 10-K · filed 2026-02-25 | $7.15M 10-K · filed 2025-02-26 | ||||
| 2024-09-30 | $5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.23M derived: sum of 2 quarters · filed 2025-11-05 | $8.87M 10-Q · filed 2025-11-05 | $8.87M 10-Q · filed 2024-11-07 | $7.31M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.31M 10-Q · filed 2025-08-05 | $3.31M 10-Q · filed 2024-08-07 | $1.74M derived: sum of 3 quarters · filed 2026-02-25 | $783.05K derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $1.65M 10-Q · filed 2025-05-12 | $1.65M 10-Q · filed 2024-05-07 | $78.24K derived: sum of 2 quarters · filed 2026-02-25 | -$876.95K derived: sum of 3 quarters · filed 2026-02-25 | -$344.43K derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.52M derived: sum of 2 quarters · filed 2026-02-25 | -$1.99M derived: sum of 3 quarters · filed 2026-02-25 | $1.58M 10-K · filed 2026-02-25 | $1.58M 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | -$955.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$422.68K derived: sum of 2 quarters · filed 2024-11-07 | $3.15M 10-Q · filed 2024-11-07 | $2.35M derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2023-06-30 | $532.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $4.10M 10-Q · filed 2024-08-07 | $3.30M derived: sum of 3 quarters · filed 2025-02-26 | $3.57M derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2023-03-31 | $3.57M 10-Q · filed 2024-05-07 | $2.77M derived: sum of 2 quarters · filed 2025-02-26 | $3.04M derived: sum of 3 quarters · filed 2025-02-26 | $10.84K derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2022-12-31 | -$801.28K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$536.09K derived: sum of 2 quarters · filed 2025-02-26 | -$3.56M derived: sum of 3 quarters · filed 2025-02-26 | -$1.31M 10-K · filed 2025-02-26 | |||||
| 2022-09-30 | $265.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.76M derived: sum of 2 quarters · filed 2023-11-14 | -$513.04K 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$778.23K 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | $2.25M 10-Q · filed 2023-05-11 | ||||||||
| 2021-12-31 | $1.57M 10-K · filed 2023-03-20 | ||||||||
| 2021-09-30 | $213.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $762.55K 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | $549.27K 10-Q · filed 2022-08-12 |